Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time

Publisher： Karger

E-ISSN： 1664-5456|3|1|35-45

ISSN： 1664-5456

Source： Cerebrovascular Diseases Extra, Vol.3, Iss.1, 2013-03, pp. : 35-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Thrombolysis Based on Diffusion-Weighted Imaging and Fluid-Attenuated Inversion Recovery Mismatch in Acute Stroke Patients with Unknown Onset Time

By  

Cerebrovascular Diseases, Vol. 31, Iss. 5, 2011-02 ,pp. : 435-441

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Dabigatran

By  

Cerebrovascular Diseases, Vol. 30, Iss. 5, 2010-09 ,pp. : 533-534

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis for Acute Ischaemic Stroke: Preliminary Experience with Recombinant Tissue Plasminogen Activator in the UK

By  

Cerebrovascular Diseases, Vol. 20, Iss. 6, 2005-11 ,pp. : 438-442

Karger

Access to resources Recommend Favorite

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Early Neurological Deterioration following Intravenous Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Lacunar Stroke

By  

Cerebrovascular Diseases, Vol. 26, Iss. 4, 2008-08 ,pp. : 355-359

Karger

Access to resources Recommend Favorite